Centiva Capital’s Advent Technologies ADN Stock Holding History

Centiva Capital’s Portfolio ADN Stock Details ADN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,667	Closed	-$517K	–	893
2020 Q3	$517K	Buy	+1,667	New	+$516K	0.03%	329

Other funds holding ADN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EJF Capital Arlington, Virginia $150M AUM 32.63% 1-Year Est. Return

ACM

Arosa Capital Management Miami Beach, Florida $660M AUM 210.26% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Centiva Capital's ADN Position: Q4 2020 in Review

Centiva Capital sold out of Advent Technologies (ADN) in Q4 2020, closing a stake of 1,667 shares — an estimated $517K sold.

Centiva Capital first reported a position in ADN in Q3 2020 and held it in 1 quarter. The position peaked at $517K in Q3 2020. 24 funds tracked by Wall St. Rank hold ADN as of Q4 2020.

Centiva Capital reported no remaining Advent Technologies position as of Q4 2020 after selling out during the quarter.
Centiva Capital sold 1,667 Advent Technologies shares in Q4 2020, an estimated $517K.
Centiva Capital first reported a position in Advent Technologies in Q3 2020 and held it in 1 quarter.
Centiva Capital's Advent Technologies position peaked at $517K in Q3 2020.
24 funds tracked by Wall St. Rank held Advent Technologies as of Q4 2020.

Based on Centiva Capital's 13F filing for Q4 2020, filed 16 Feb 2021.